KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Deferred Taxes (2020 - 2026)

Pacira BioSciences has reported Deferred Taxes over the past 7 years, most recently at $1.7 million for Q1 2026.

  • For Q1 2026, Deferred Taxes rose 23.84% year-over-year to $1.7 million; the TTM value through Mar 2026 reached $6.8 million, down 63.3%, while the annual FY2025 figure was $6.5 million, 68.59% down from the prior year.
  • Deferred Taxes for Q1 2026 was $1.7 million at Pacira BioSciences, up from -$3.7 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at $12.5 million in Q2 2024 and troughed at -$10.8 million in Q4 2022.
  • A 5-year average of $2.1 million and a median of $1.7 million in 2026 define the central range for Deferred Taxes.
  • Biggest five-year swings in Deferred Taxes: plummeted 25417.24% in 2023 and later surged 623.95% in 2025.
  • Year by year, Deferred Taxes stood at -$10.8 million in 2022, then soared by 160.89% to $6.6 million in 2023, then crashed by 46.86% to $3.5 million in 2024, then crashed by 206.73% to -$3.7 million in 2025, then skyrocketed by 146.21% to $1.7 million in 2026.
  • Business Quant data shows Deferred Taxes for PCRX at $1.7 million in Q1 2026, -$3.7 million in Q4 2025, and $8.1 million in Q3 2025.